Artificial intelligence (AI) and machine learning (ML) are being used to innovate drug development, particularly for cancer treatments. These advancements can make treatments faster, more cost-effective, and lead to more personalized and effective cancer therapies.
Managing Self-funded Risk
October 09, 2024
High-Cost Claims Spotlight: AI and Cancer Drug Development
August 14, 2024
The Value of Second Opinions – Cancer
A second medical opinion can have a substantial influence on a patient’s well-being, treatment, and prognosis. Learn what you can do to help your employees manage these decisions more effectively, gain the confidence to make medical decisions, and how Health Navigator can help.
June 28, 2024
Gene Therapies Update: Hemophilia
The FDA recently approved gene therapies used to treat hemophilia A and B. This Sun Life Bright Paper dives deeper into Roctavian and Hemgenix, other treatments, their costs, and more. This is a big step forward in hemophilia care!
May 15, 2024
Mental health impacts of a breast cancer diagnosis
Breast cancer is one of the most common cancers in women in the U.S., and can take a severe emotional and mental toll on patients and their families. Sun Life's Bright Paper discusses the link between mental health and breast cancer, barriers to access treatment, recommendations, and more.
April 02, 2024
Spotlight on kidney disease: Assessing and addressing the risks
March 22, 2024
Arthritis cost review: High-cost prescription and injectable drugs update
February 28, 2024
2024 Updates and 2023 Year in Review on Leave and Accommodations Webinar
Watch Marjory Robertson, AVP & Senior Counsel, Sun Life and Abigail O’Connell, Senior Counsel, Sun Life, for a recap of 2023 legal and compliance developments related to leave and accommodation law.
January 16, 2024
2024 Future Forecast Video Series: Improving the Medical Moment
September 20, 2023
2023 Updates on Leave and Accommodation laws
Watch as Marjory Robertson, AVP & Senior Counsel, Sun Life U.S. and Abigail O’Connell, Senior Counsel, recap the latest 2023 leave and accommodation-related compliance developments.
May 17, 2023
2023 High-cost claims and injectable drug trends analysis
For the past eleven years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims.
February 08, 2023
2023 Future Forecast with Jennifer Collier and James Slotnick
What's top of mind for Sun Life leaders?
February 06, 2023
Introduction to Gene Therapies (3rd edition)
Learn more about recently approved Hemgenix in the treatment of Hemophilia B, the gene therapy pipeline, the approval process, and what gene therapies are, in our second edition of the Introduction to Gene Therapies paper.
September 29, 2022
Impacts of Blood Cancer: Blood Cancer was the #2 high-cost claims condition and nearly 10% of 2021 total spend within Sun Life’s Health & Risk Solutions book of business
Every three minutes, someone in the U.S. is diagnosed with blood cancer.